Vaisala Group
6.3.2026 13:00:00 CET | Globenewswire | Press release
Vaisala Corporation: Managers’ Transactions – Gulli, Lorenzo
Vaisala Corporation: Managers’ Transactions – Gulli, Lorenzo
Vaisala Corporation
Managers’ Transactions
March 6, 2026, at 2:00 p.m. (EET)
Vaisala Corporation: Managers’ Transactions – Gulli, Lorenzo
____________________________________________
Person subject to the notification requirement
Name: Gulli, Lorenzo
Position: Other senior manager
Issuer: Vaisala Oyj
LEI: 743700RNDD7KU11HW873
Notification type: INITIAL NOTIFICATION
Reference number: 743700RNDD7KU11HW873_20260305144424_86
____________________________________________
Transaction date: 2026-03-05
Venue not applicable
Instrument type: SHARE
ISIN: FI0009900682
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE
Transaction details
(1): Volume: 500 Unit price: 0.00 EUR
Aggregated transactions
(1): Volume: 500 Volume weighted average price: 0.00 EUR
More information:
Niina Ala-Luopa, investor relations
+358 400 728 957, ir@vaisala.com
Distribution:
Nasdaq Helsinki
Key media
vaisala.com
Vaisala is a global leader in measurement instruments and intelligence for climate action. We equip our customers with devices and data to improve resource efficiency, drive energy transition, and care for the safety and well-being of people and societies worldwide. With over 90 years of innovation and expertise, we employ a team of close to 2,500 experts committed to taking every measure for the planet. Vaisala series A shares are listed on the Nasdaq Helsinki stock exchange.
www.vaisala.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Norvault23.10.2026 16:29:06 CEST | Press release
NORVAULT AG extends Bacon Series 001 offer and tender timetable
XBiotech Inc.23.10.2026 15:17:07 CEST | Press release
XBiotech Announces Election of Sushma Shivaswamy and Jan-Paul Simard as Co-Chief Executive Officers
Precede Biosciences, Inc.23.10.2026 15:15:00 CEST | Press release
Precede Biosciences Presents ESMO 2026 Data Revealing Biology Associated with Response and Resistance to PSMA-Directed Radioligand Therapy in Advanced Prostate Cancer
Golar LNG23.10.2026 14:16:21 CEST | Press release
Golar releases 2025 Environmental, Social and Governance report
Novartis Pharma AG23.10.2026 13:30:00 CEST | Press release
Kisqali® shows clinically meaningful overall survival in broadest HR+/HER2- early breast cancer population at high risk of recurrence
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom